Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®

B TORONTO, May 1, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), Canada’s largest Canadian‑based global health company, today announced that Health Canada has…
posteditor
posteditor
Articles: 17424

Other News